Monsanto's (NYSE: MON) stock has not cooperated since the June 15, 2009 Buy recommendation, as the shares have drifted about 10% lower. Still, nothing has changed regarding MON's value proposition, hence I'm Reiterating my June 15, 2009 Buy recommendation, when shares were at $84.97. Higher-value-added, next-generation seeds will see substantial demand increases as the economic recovery progresses. Moreover, there is ample room to expand international sales, as emerging markets continue to develop their agriculture sectors and seek higher per acre yields.


For or against them, bioengineered crops are here to stay and are likely to continue to play a pivotal role in economic development in emerging markets. A company destined to remain a force in this space is
Agrium

